Clinical and Resistance Consequences of Misquantification of Plasma and Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Samples from an HIV-1 Subtype G-Infected Patient

被引：13

作者：

Delaugerre, Constance ^{[1
]}

Denis, Blandine ^{[2
]}

Peytavin, Gilles ^{[3
]}

Palmer, Pierre ^{[1
]}

Mourez, Thomas ^{[1
]}

Le Goff, Jerome ^{[1
]}

Molina, Jean-Michel ^{[2
]}

Simon, Francois ^{[1
]}

机构：

[1] Hop St Louis, Dept Virol, APHP, F-75010 Paris, France

[2] Hop St Louis, Dept Infect Dis, APHP, F-75010 Paris, France

[3] Hop Bichat Claude Bernard, Dept Pharmacol, APHP, F-75877 Paris, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2009年 / 47卷 / 11期

关键词：

ABBOTT REALTIME; COBAS-TAQMAN; QUANTIFICATION; DISCREPANCIES; ASSAYS; LOAD;

D O I：

10.1128/JCM.00206-09

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Human immunodeficiency virus (HIV) load is the main marker used to monitor antiviral treatment efficacy and resistance. We report a case of underquantification of HIV type 1 (HIV-1) RNA in plasma and cerebrospinal fluid from an HIV-1 subtype G-infected woman, leading to delayed diagnosis of HIV encephalitis and to the emergence of drug resistance.

引用

页码：3763 / 3764

页数：2

共 50 条

[31] Relationships among cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) culture, quinolinic acid level, and reaction time in HIV-1-infected individuals
Mapou, RL
Law, WA
Heyes, MP
Turnicky, R
Ling, GSF
Dopler, B
Martin, A
Brown, D
Temoshok, LR
NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 1996, 9 (01): : 43 - 49
[32] A SIMPLIFIED METHOD FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA IN PLASMA - CLINICAL CORRELATES
STRICKER, RB
ZHU, YS
ELSWOOD, BF
RESEARCH IN VIROLOGY, 1995, 146 (02): : 151 - 158
[33] Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission
Panther, LA
Tucker, L
Xu, C
Tuomala, RE
Mullins, JI
Anderson, DJ
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 555 - 563
[34] Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17
Kageyama, S
Katsumoto, T
Taniguchi, K
Ismail, SI
Shimmen, T
Sasao, F
Gao, M
Owatari, S
Wakamiya, N
Tsuchie, H
Ueda, S
Shiraki, K
Kurimura, T
ACTA VIROLOGICA, 1996, 40 (04) : 195 - 200
[35] Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain
Girard, M
Yue, L
BarreSinoussi, F
VanderRyst, E
Meignier, B
Muchmore, E
Fultz, PN
JOURNAL OF VIROLOGY, 1996, 70 (11) : 8229 - 8233
[36] Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
Dirac, AMG
Huthoff, H
Kjems, J
Berkhout, B
JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 2533 - 2542
[37] Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B
Frost, SDW
Liu, Y
Pond, SLK
Chappey, C
Wrin, T
Petropoulos, CJ
Little, SJ
Richman, DD
JOURNAL OF VIROLOGY, 2005, 79 (10) : 6523 - 6527
[38] Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections
John, GC
Nduati, RW
Mbori-Ngacha, DA
Richardson, BA
Panteleeff, D
Mwatha, A
Overbaugh, J
Bwayo, J
Ndinya-Achola, JO
Kreiss, JK
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02): : 206 - 212
[39] Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype
Paraskevis, D
Magiorkinis, E
Magiorkinis, G
Anastassopoulou, C
Lazanas, M
Chrysos, G
Vandamme, AM
Hatzakis, A
JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 2509 - 2514
[40] Cerebrospinal fluid and plasma HIV-1 RNA stability at 4°C
Ahmad, M
Tashima, KT
Caliendo, AM
Flanigan, TP
AIDS, 1999, 13 (10) : 1281 - 1282

← 1 2 3 4 5 →